Walleye Trading
LMAT icon

Walleye Trading’s LeMaitre Vascular LMAT Stock Holding History

Walleye Trading’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-2,300
Closed -$28K – 5270
2015
Q2 		$28K Buy
+2,300
New +$22.6K ﹤0.01% 3830

Other funds holding LMAT

AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

Walleye Trading's LMAT Position: Q3 2015 in Review

Walleye Trading sold out of LeMaitre Vascular (LMAT) in Q3 2015, closing a stake of 2,300 shares — an estimated $28K sold.

Walleye Trading first reported a position in LMAT in Q2 2015 and held it in 1 quarter. The position peaked at $28K in Q2 2015. 87 funds tracked by Wall St. Rank hold LMAT as of Q3 2015.

  • Walleye Trading reported no remaining LeMaitre Vascular position as of Q3 2015 after selling out during the quarter.
  • Walleye Trading sold 2,300 LeMaitre Vascular shares in Q3 2015, an estimated $28K.
  • Walleye Trading first reported a position in LeMaitre Vascular in Q2 2015 and held it in 1 quarter.
  • Walleye Trading's LeMaitre Vascular position peaked at $28K in Q2 2015.
  • 87 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2015.

Based on Walleye Trading's 13F filing for Q3 2015, filed 16 Nov 2015.